BGM Announces Collaborative Research Study with Mitsubishi Pharma
News Mar 30, 2006
BG Medicine (BGM) will apply their proprietary, integrated systems approach based on proteomics, metabolomics and computational analyses to describe the molecular effects of selected lipid lowering agents on skeletal muscle and to identify specific plasma biomarkers of these effects.
Mitsubishi Pharma Corporation will contribute transcript, clinical chemistry and histopathology data to the effort.
Muscle toxicity in lipid - lowering agents, a common adverse effect of these agents, covers a broad spectrum from mild and transient muscle pain to the extremely rare but serious acute muscle destruction.
"This exciting project uses BG Medicine's commercial systems toxicology platform to characterize and compare the molecular effects of two lipid lowering compounds at the dosages in which histopathological changes in muscle were observed in some animals," said Pieter Muntendam, MD, President and CEO of BG Medicine.
"In this context it is a great example of how systems toxicology and pharmacology provide early insightful biology for pertinent drug development decisions."
Under this agreement BG Medicine and Mitsubishi Pharma Corporation will jointly own certain rights to the project data and biomarkers.
The spatial and temporal dynamics of proteins or organelles plays a crucial role in controlling various cellular processes and in development of diseases. However, acute control of activity at distinct locations within a cell cannot be achieved. A new chemo-optogenetic method enables tunable, reversible, and rapid control of activity at multiple subcellular compartments within a living cell.
Scientists from the UNC School of Medicine discovered that the anti-inflammatory protein NLRP12 normally helps protect mice against obesity and insulin resistance when they are fed a high-fat diet. The researchers also reported that the NLRP12 gene is underactive in people who are obese, making it a potential therapeutic target for treating obesity and diabetes.READ MORE